FDA Inspection 1191129 — Fischer ANalysen Instrumente GmbH

Fischer ANalysen Instrumente GmbH — FEI 3010837197

The FDA completed an inspection of Fischer ANalysen Instrumente GmbH on Nov 4, 2022 in Leipzig. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Nov 4, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Project Evaluation: Devices
Location
Leipzig (Germany)

Additional Details

Postmarket Audit Inspections

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1471721 CFR 820.30(g)Design validation - software validation documentation
311721 CFR 820.70(i)Software validation for automated processes
313021 CFR 820.100(a)Lack of or inadequate procedures
323521 CFR 820.72(a)Equipment control activity documentation
340921 CFR 820.200(d)Service reports
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.